JAMA study finds cancer drug data is still largely unavailable to qualified researchers

As data sharing has become more helpful and relevant to researchers in the past few years, a new report in JAMA Oncology shows that the availability of cancer drugs’ clinical trial data is still lagging for researchers.

An audit from Australian researchers found that less than...

Click to view original post